Previous 10 | Next 10 |
2023-06-21 10:17:50 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Spotify (NYSE: SPOT ) stock is moving on Wednesday following an upgrade from Wolfe Research analyst Zach Morrissey. The Wolfe Research analyst upgraded shares of SPOT from a...
2023-06-21 09:27:06 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cabaletta Bio (NASDAQ: CABA ) stock is falling on Wednesday following news of insider selling at the targeted cell therapy company. Gwendolyn Binder, the President of Scienc...
2023-06-20 17:42:47 ET Gainers: 2U ( TWOU ) +7% . Silk Road Medical ( SILK ) +4% . ROC Energy Acquisition ( ROC ) +4% . AXT ( AXTI ) +4% . CVB Financial ( CVBF ) +3% . Losers: LifeStance Health Group ( LFST ) ...
Dr. Brun also appointed as Chairperson of Jasper Research and Development Committee and to Compensation Committee Board member Vishal Kapoor appointed to Jasper Audit and Compensation Committees REDWOOD CITY, Calif., June 20, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nas...
PHILADELPHIA, May 22, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases...
2023-05-19 15:00:19 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week, or the Seeking Alpha earnings calendar ...
Cabaletta Bio, Inc. (NASDAQ: CABA) is the focus of IBN's latest stock spotlight. The company's shares have moved 0.66% on the day to $12.21. Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B ...
2023-05-18 10:59:22 ET S3 Partners dug into the short interest data on U.S. stocks to find the names that are seeing the most pressure exerted on investors with short positions. Ihor Dusaniwsky filtered the stock universe to pull out squeeze candidates with over $50M worth of short inte...
2023-05-18 02:41:30 ET Cabaletta Bio ( NASDAQ: CABA ) prices underwritten public offering of 7.25M shares at a public offering price of $12.00 per share. Underwriters have a 30-day option to purchase up to an additional ~1.09M shares. Gross proceeds are expected to be ...
PHILADELPHIA, May 17, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases...
News, Short Squeeze, Breakout and More Instantly...
PHILADELPHIA, July 02, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced that Steven Nichtb...
2024-06-20 09:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
– No CRS, ICANS, infections or serious adverse events observed in either of the first two patients through data cut-off of May 28, 2024 – – CABA-201 exhibited anticipated profile of CAR T cell expansion and contraction with complete B cell depletion observed in both...